-
Apr 25, 2024 | 
cellandgene.com | Geraldine Carr-Mulry |Marwan Alsarraj
Webinar: Continuously improving Quality and Efficiency in AAV ManufacturingIn this webinar you'll learn how to accelerate timelines while increasing quality aspects in AAV manufacturing as well as the benefits of IDT Biologika's AAV capabilities and platform approach. Make sure to tune in on May 16th for an outlook for upcoming technologies and evaluation from a GMP manufacturer perspective. Click here to learn more.
-
Feb 5, 2024 | 
theanalyticalscientist.com | Marwan Alsarraj
The issue of antibiotic resistance is a critical concern in clinical settings, with the World Health Organization ranking it among the top 10 global health issues in 2021. The misuse and potential overuse of antibiotics have resulted in widespread and sometimes unchecked antibiotic resistance, costing the United States alone over $4 billion annually. However, methods of assessing antibiotic resistance need to be faster and more consistent.
-
Dec 12, 2023 | 
labmanager.com | Marwan Alsarraj
Capital equipment can be defined as a high-cost fixed asset (i.e., a confocal microscope) that enables a laboratory to continue or expand its current research or business capabilities. Whilst the purchase of consumable reagents and relatively low-cost equipment (i.e., a pH meter) can come from an operational budget, the purchase of capital equipment relies on a capital expenditure (CapEx) budget.
-
Dec 12, 2023 | 
labmanager.com | Marwan Alsarraj
Marwan AlsarrajMarwan Alsarraj is the biopharma segment manager, Digital Biology Group, at Bio-Rad. He has been at the forefront of developing, marketing, and commercializing technologies in the past 15 years in the life science research industry. Marwan obtained his MS in biology at the University of Texas, El Paso.
-
Aug 25, 2023 | 
bioprocessonline.com | Aditi Shivarkar |Richard Steiner |Marwan Alsarraj
Stem cell assays allow scientists to assess the self-renewal capacity, proliferation rate, differentiation potential, and other characteristics of stem cells. By understanding how stem cells respond to different conditions, scientists can optimize protocols for therapeutic use. Let's look at six emerging trends in using stem cell assays.
-
Aug 22, 2023 | 
themedicinemaker.com | Marwan Alsarraj
Gene therapies have set the pharmaceutical world’s passion and imagination ablaze, but the manufacture of these advanced therapies presents fundamental challenges that biomanufacturers must address to ensure proper quality control and patient safety. Though gene therapies may employ a variety of viral vectors to deliver a genetic payload, AAV-based gene therapies are currently the most popular platform.
-
Aug 22, 2023 | 
brnw.ch | Marwan Alsarraj
Gene therapies have set the pharmaceutical world’s passion and imagination ablaze, but the manufacture of these advanced therapies presents fundamental challenges that biomanufacturers must address to ensure proper quality control and patient safety. Though gene therapies may employ a variety of viral vectors to deliver a genetic payload, AAV-based gene therapies are currently the most popular platform.
-
Aug 9, 2023 | 
themedicinemaker.com | Marwan Alsarraj
After entering into a licensing agreement with DualityBio earlier this year, Adcendo is now further extending the collaboration to look at even more antibody drug conjugate (ADC) targets. “Based on the agreement, new targets will be evaluated under the material transfer agreement with Duality’s linker-payload platform, designed to generate ADCs with superior safety profiles, sustainable payload delivery and release in tumors, and efficient bystander killing of antigen low and negative cells.
-
May 30, 2023 | 
biopharmadive.com | Marwan Alsarraj
Innovative cell and gene therapies could hold the keys to treating and potentially curing a wide range of genetic and acquired diseases. Among the arsenal of tools available to researchers and biopharmaceutical experts, lentiviral vectors have long been recognized as a versatile platform for delivering genetic material into target cells.
-
Mar 2, 2023 | 
invesbrain.com | Marwan Alsarraj |James Steiner-Dillon |Kathy Vuksanaj
Does wearing a mask stop the spread of COVID-19? Is climate change driven primarily by human-made emissions? With these kinds of issues dividing the public, it sometimes feels as if Americans are losing our ability to agree about basic facts of the world. There have been widespread disagreements about matters of seemingly objective fact in the past, yet the number of recent examples can make it feel as though our shared sense of reality is shrinking.
